|
|||||
|
|
| 中药防治CVB_3病毒性心肌炎实验研究进展 | |
| 引用本文： | 郑彩慧,韩淑英,吴范武,吕立勋,包巨太. 中药防治CVB_3病毒性心肌炎实验研究进展[J]. 辽宁中医杂志, 2012, 0(1): 184-186 |
| 作者姓名： | 郑彩慧 韩淑英 吴范武 吕立勋 包巨太 |
| 作者单位： | 河北联合大学中医学院;河北联合大学基础医学院;河北联合大学药学院 |
| 基金项目： | 科技部“重大新药创新”科技重大专项项目课题资助(2009ZX09103-442) |
| 摘 要： | CVB3是病毒性心肌炎的主要致病因素,目前西医对CVB3病毒性心肌炎的治疗尚无特效药物。近年来,中医药对CVB3的治疗取得了一定的成就。大量的动物实验表明,单味药和复方广泛用于CVB3的治疗,具有部分直接杀灭病毒、抑制病毒复制、抗氧化、保护心肌细胞,调节免疫功能以及参与心肌细胞的凋亡等。文章对近年中药防治CVB3病毒性心肌炎从实验研究的角度做一综述。 |
| 关 键 词： | 中药 CVB3 实验研究 综述 |
Research Progress of TCM Treatment And Prevention of CVB3 Viral Myocarditis |
|
| ZHENG Cai-hui,Han Shu-ying,WU Fan-wu,LU Li-xun,BAO Ju-tai. Research Progress of TCM Treatment And Prevention of CVB3 Viral Myocarditis[J]. Liaoning Journal of Traditional Chinese Medicine, 2012, 0(1): 184-186 | |
| Authors: | ZHENG Cai-hui Han Shu-ying WU Fan-wu LU Li-xun BAO Ju-tai |
| Affiliation: | 1(1.TCM College of Hebei United University,Tangshan 063000,Hebei,China; 2.Basic Medicine School of Hebei United University,Tangshan 063000,Hebei,China; 3.Pharmacy School of Hebei United University,Tangshan 063000,Hebei,China) |
| Abstract: | CVB3 viral myocarditis is a major risk factor.Currently western medicine has no effective drug for treating Coxsackie B3 viral myocarditis.In recent years,Chinese medicine for treating CVB3 achieved some success.A large number of animal experiments show that many traditional Chinese medicine with the prevention and treatment function has significant effect on CVB3.In this paper,traditional Chinese medicine in recent years,prevention and treatment of Coxsackie B3 viral myocarditis were reviewed from the perspective of experimental studies. |
| Keywords: | TCM CVB3 myocarditis experimental study review |
| 本文献已被 CNKI 维普 等数据库收录！ | |